SCHEMBL12037331

SCHEMBL12037331

c1ccc2c(c1)cc(-c1ccc3oc4ccc(-c5ccc6cc(-c7ccc8c9ccccc9c9ccccc9c8c7)ccc6c5)cc4c3c1)c1ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.42
KDM4E B2RXH2 7/20 0.41
MAPT P10636 4/20 0.41
HPGD P15428 3/20 0.41
TSHR P16473 2/20 0.41
HSD17B10 Q99714 2/20 0.41
GLA P06280 2/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 6/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
HNF4A P41235 1/20 0.40
MIF P14174 1/20 0.40
CYP11B1 P15538 1/20 0.40
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12037276 0.97 KDM4E (0.43) GPR84KDM4EMAPTHPGDTSHR
SCHEMBL16417804 0.97 GPR84 (0.43) GPR84KDM4EMAPTHPGDTSHR
SCHEMBL12037259 0.97 GPR84 (0.43) GPR84KDM4EMAPTHPGDTSHR
SCHEMBL12037332 0.95 GPR84 (0.41) GPR84KDM4EMAPTHPGDTSHR
SCHEMBL12037253 0.95 GPR84 (0.46) GPR84KDM4EMAPTHPGDTSHR
SCHEMBL12037570 0.94 KDM4E (0.44) GPR84KDM4EMAPTHPGDTSHR
SCHEMBL12037248 0.94 GPR84 (0.45) GPR84KDM4EMAPTHPGDTSHR
SCHEMBL12037296 0.94 KDM4E (0.45) KDM4EMAPTHPGDTSHRHSD17B10
SCHEMBL12037407 0.94 KDM4E (0.45) KDM4EMAPTHPGDTSHRHSD17B10
SCHEMBL12037288 0.94 GPR84 (0.45) GPR84KDM4EMAPTHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8940412-B2 Material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-01-27 US disclosed
US-8940412-B2 Material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-01-27 US disclosed
US-20110315965-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2011-12-29 US disclosed
US-20110315965-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110315965-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT LEF1, TERF2, BPTF GPR84 4594/4885KDM4E 1891/4885MAPT 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.